Mechanism of Yangxin Tongmai Decoction in the Treatment of Coronary Heart Disease with Blood Stasis Syndrome Based on Network Pharmacology and Molecular Docking

This study aimed to explore the mechanism of Yangxin Tongmai decoction (YXTMD) in the treatment of coronary heart disease (CHD) with blood stasis syndrome (BSS) using network pharmacology and molecular docking, and to verify these results through clinical trials. The active compounds of YXTMD were i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengxue, Liu, Jia, Zhang, Xiangzhuo, Zhang, Shumeng, Jiang, Yujie, Yu, Zixuan, Xie, Ting, Chen, Yuxia, Chen, Lingli, Li, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546682/
https://www.ncbi.nlm.nih.gov/pubmed/36212940
http://dx.doi.org/10.1155/2022/4692217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546682/
https://www.ncbi.nlm.nih.gov/pubmed/36212940
http://dx.doi.org/10.1155/2022/4692217

Ejemplares similares